Immunolesions of glucoresponsive projections to the arcuate nucleus alter glucoprivic-induced alterations in food intake, luteinizing hormone secretion, and GALP mRNA, but not sex behavior in adult male rats.
Metabolic signals such as insulin, leptin and glucose are known to alter hypothalamic function. Although insulin and leptin are known to directly alter hypothalamic areas that regulate reproduction, the mechanisms by which glucose alters reproductive function are not as clear. Catecholaminergic neurons in the A1/C1 region in the hindbrain are glucose-responsive and project to the arcuate nucleus. To determine if this pathway is involved in the regulation of sex behavior and luteinizing hormone (LH) secretion, this catecholaminergic pathway was lesioned with injections of saporin conjugated with anti-dopamine-beta-hydroxylase (DSAP) or unconjugated saporin (SAP) in adult male rats. Rats were given glucoprivic challenges and feeding and sex behavior was observed. As was expected, the DSAP-treated rats showed decreased feeding during glucoprivation (250 mg/kg 2-deoxy-D-glucose, 2DG) compared to SAP controls. Glucoprivation caused a significant reduction in sex behavior in both SAP and DSAP animals equally, compared to saline treatments (p < 0.05). At the end of the experiment, animals were given a final challenge with 2DG or saline, euthanized by decapitation and trunk blood was assayed for plasma LH levels. In situ hybridization analysis revealed that 2DG treatment caused a significant reduction in GALP mRNA in SAP controls compared to saline treatment. This reduction in GALP mRNA was prevented with DSAP treatment. In SAP animals, 2DG elicited a significant decrease in plasma LH levels (p < 0.05); this reduction in plasma LH was absent in the DSAP-treated male rats. These data indicate that the A1/C1 efferents to the ventromedial hypothalamus are involved in the glucostatic regulation of GALP mRNA, feeding behavior and LH secretion, but not sex behavior in the adult male rat.
Fraley
Gregory S
GS
Biology Department, Hope College, Holland, MI 49423, USA. fraley@hope.edu
D000818:Animals; D000906:Antibodies / Q000633:toxicity; D001111:Arcuate Nucleus of Hypothalamus / Q000187:drug effects / Q000293:injuries / Q000378:metabolism*; D002452:Cell Count / Q000379:methods; D003847:Deoxyglucose / Q000494:pharmacology; D004299:Dopamine beta-Hydroxylase / Q000276:immunology; D004435:Eating / Q000187:drug effects / Q000502:physiology*; D044089:Galanin-Like Peptide / Q000235:genetics / Q000378:metabolism*; D005786:Gene Expression Regulation / Q000187:drug effects / Q000502:physiology; D005947:Glucose / Q000172:deficiency*; D007150:Immunohistochemistry / Q000379:methods; D000922:Immunotoxins / Q000633:toxicity; D017403:In Situ Hybridization / Q000379:methods; D007986:Luteinizing Hormone / Q000378:metabolism*; D008297:Male; D009434:Neural Pathways / Q000187:drug effects / Q000293:injuries / Q000502:physiology*; D012333:RNA, Messenger / Q000378:metabolism; D011863:Radioimmunoassay / Q000379:methods; D051381:Rats; D017207:Rats, Sprague-Dawley; D020133:Reverse Transcriptase Polymerase Chain Reaction / Q000379:methods; D012726:Sexual Behavior, Animal / Q000187:drug effects / Q000502:physiology
D000906:Antibodies; D044089:Galanin-Like Peptide; D000922:Immunotoxins; D012333:RNA, Messenger; D007986:Luteinizing Hormone; D003847:Deoxyglucose; D004299:Dopamine beta-Hydroxylase; D005947:Glucose